STOCKHOLM, Nov. 18, 2019 /PRNewswire/ -- Scandinavian
ChemoTech and its CEO Mohan Frick
has been selected to present its Tumour Specific Electroporation at
the Emerging Medtech Summit in California, USA. An event bringing together
the top strategists, investors, and innovators within the Medtech
industry.
The summit is a 3-day event where ChemoTech and other medical
device companies will present their innovations to some of the
largest medical device companies and institutional investors, such
as: Medtronic, Johnson & Johnson, Boston Scientific, Wells
Fargo, China Bio Group and many others.
After ChemoTech's unique platform for Tumour Specific
Electroporation recently was granted two very important patents,
ChemoTech actively searches for strategic alliances and
collaborations for licensing its Tumour Specific Electroporation
platform.
"We feel honoured to have received the opportunity to present
our company and our platform to an audience of this dignity. It's
going to be very interesting to see what kind of attention we can
achieve during this summit", says Mohan
Frick, CEO of Scandinavian ChemoTech.
The Emerging MedTech summit will take place at the Ritz -
Carlton in Laguna Niguel
California 18th to 20th of
February 2020.
To read more about this summit, please press here.
For further information please contact:
Mohan Frick, CEO
+46(0)10-218-93-00
info@chemotech.se
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/chemotech/r/scandinavian-chemotech-and-its-ceo-mohan-frick-participates-and-presents-at-the-emerging-medtech-sum,c2962994
The following files are available for download:
https://mb.cision.com/Main/14967/2962994/1145964.pdf
|
Release
|
View original
content:http://www.prnewswire.com/news-releases/scandinavian-chemotech-and-its-ceo-mohan-frick-participates-and-presents-at-the-emerging-medtech-summit-in-california-usa-300959753.html
SOURCE ChemoTech